Walmart launches telehealth campaign with Doctor on Demand

Retail giant Walmart has partnered with consumer health and hygiene company RB to launch a telehealth initiative with Doctor on Demand, a virtual care provider. The initiative, which is limited in scope and will offer some consumers a free telehealth visit with Doctor on Demand, is a campaign that aims to boost the clout of telehealth.

Walmart employees already can use Doctor on Demand services. The telehealth company has direct contracts with several large employers.

The announcement follows in the steps of healthcare retailers such as CVS Health, which rolled out its new telehealth pilot earlier this fall. Many healthcare companies are ramping up telehealth capabilities to better serve consumers, who face an average wait of 18 days to schedule an appointment with a doctor, according to RB.

Walmart has also been exploring other healthcare opportunities, including a rumored acquisition of health insurance company Humana and collaborating with other health plans.

Specifically, consumers who buy certain over-the-counter medicines, including Mucinex, Delsym, Airborne or Digestive Advantage, will receive a free telehealth medical consultation with a Doctor on Demand physician this fall.

Doctor on Demand, which launched in late 2013, surpassed one million video visits in May this year.

“Despite consumers' desire to take more control of their health, the path isn't always clear, and access to fast, reliable and affordable healthcare solutions remains a cause of stress," Gregory Chabidon, chief medical officer of USA at RB Health Unit, said in a statement. "The program with Doctor On Demand at the start of cough, cold & flu season is designed to help improve access to healthcare at just the right time.”

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

FDA Commissioner Robert Califf, MD, said the clinical community needs to combat health misinformation at a grassroots level. He warned that patients are immersed in a "sea of misinformation without a compass."
 

With generative AI coming into its own, AI regulators must avoid relying too much on principles of risk management—and not enough on those of uncertainty management.

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Trimed Popup
Trimed Popup